Merino-Sanjuan M - Search Results

1

N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.

Mura C, Nácher A, Merino V, Merino-Sanjuan M, Carda C, Ruiz A, Manconi M, Loy G, Fadda AM, Diez-Sales O. Mura C, et al. Int J Pharm. 2011 Sep 15;416(1):145-54. doi: 10.1016/j.ijpharm.2011.06.025. Epub 2011 Jun 23. Int J Pharm. 2011. PMID: 21723929

2

Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.

Ruiz-Carretero P, Nacher A, Merino-Sanjuan M, Casabo VG. Ruiz-Carretero P, et al. Int J Pharm. 2000 Jul 20;202(1-2):89-96. doi: 10.1016/s0378-5173(00)00420-8. Int J Pharm. 2000. PMID: 10915930

3

Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.

Ruiz-Balaguer N, Nacher A, Casabo VG, Merino Sanjuan M. Ruiz-Balaguer N, et al. Int J Pharm. 2002 Mar 2;234(1-2):101-11. doi: 10.1016/s0378-5173(01)00956-5. Int J Pharm. 2002. PMID: 11839441

4

Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.

Ruiz-Carretero P, Merino-Sanjuán M, Nácher A, Casabó VG. Ruiz-Carretero P, et al. Eur J Pharm Sci. 2004 Feb;21(2-3):217-23. doi: 10.1016/j.ejps.2003.10.006. Eur J Pharm Sci. 2004. PMID: 14757493

5

Use of nonlinear mixed effect modeling for the intestinal absorption data: application to ritonavir in the rat.

Muñoz MJ, Merino-Sanjuán M, Lledó-García R, Casabó VG, Máñez-Castillejo FJ, Nácher A. Muñoz MJ, et al. Eur J Pharm Biopharm. 2005 Sep;61(1-2):20-6. doi: 10.1016/j.ejpb.2005.03.008. Eur J Pharm Biopharm. 2005. PMID: 16005197

6

Relevance of multidrug resistance proteins on the clinical efficacy of cancer therapy.

Merino V, Jiménez-Torres NV, Merino-Sanjuán M. Merino V, et al. Curr Drug Deliv. 2004 Jul;1(3):203-12. doi: 10.2174/1567201043334650. Curr Drug Deliv. 2004. PMID: 16305384 Review.

7

Bioavailability and pharmacokinetic model for ritonavir in the rat.

Lledó-García R, Nácher A, Prats-García L, Casabó VG, Merino-Sanjuán M. Lledó-García R, et al. J Pharm Sci. 2007 Mar;96(3):633-43. doi: 10.1002/jps.20683. J Pharm Sci. 2007. PMID: 17078039

8

Population modelling to describe pharmacokinetics of amiodarone in rats: relevance of plasma protein and tissue depot binding.

Campos Moreno E, Merino Sanjuán M, Merino V, Nácher A, Martín Algarra RV, Casabó VG. Campos Moreno E, et al. Eur J Pharm Sci. 2007 Feb;30(2):190-7. doi: 10.1016/j.ejps.2006.11.006. Epub 2006 Nov 17. Eur J Pharm Sci. 2007. PMID: 17218087

9

Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.

Merino V, Micó-Albiñana T, Nácher A, Díez-Sales O, Herráez M, Merino-Sanjuán M. Merino V, et al. J Pharm Pharmacol. 2008 Apr;60(4):415-20. doi: 10.1211/jpp.60.4.0002. J Pharm Pharmacol. 2008. PMID: 18380912

10

Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation.

Escobar-Chávez JJ, Merino V, Díez-Sales O, Nácher-Alonso A, Ganem-Quintanar A, Herráez M, Merino-Sanjuán M. Escobar-Chávez JJ, et al. Pharm Dev Technol. 2011 Apr;16(2):162-9. doi: 10.3109/10837450903584902. Epub 2010 Feb 9. Pharm Dev Technol. 2011. PMID: 20141498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters